Related Experiment Video
Updated: Sep 20, 2025

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
Genetic and Epigenetic Mechanisms Deregulate the CRL2pVHL Complex in Hepatocellular Carcinoma
Brenda C Minatel1, David E Cohn1, Michelle E Pewarchuk1
1Department of Integrative Oncology, British Columbia Cancer Research Institute, Vancouver, BC, Canada.
Abstract:
Dysregulation of ubiquitin-proteasome pathway genes through copy number alteration, promoter hypomethylation, and miRNA deregulation is involved in cancer development and progression. Further characterizing alterations in these genes may uncover novel drug targets across a range of diseases in which druggable alterations are uncommon, including hepatocellular carcinoma (HCC). We analyzed 377 HCC and 59 adjacent non-malignant liver tissue samples, focusing on alterations to component genes of the widely studied CRL2pVHL E3 ubiquitin ligase complex. mRNA upregulation of the component genes was common, and was correlated with DNA hypomethylation and copy number increase, but many tumours displayed overexpression that was not explained by either mechanism. Interestingly, we found 66 miRNAs, including 39 previously unannotated miRNAs, that were downregulated in HCC and predicted to target one or more CRL2pVHL components. Several miRNAs, including hsa-miR-101-3p and hsa-miR-139-5p, were negatively correlated with multiple component genes, suggesting that miRNA deregulation may contribute to CRL2pVHL overexpression. Combining miRNA and mRNA expression, DNA copy number, and methylation status into one multidimensional survival analysis, we found a significant association between greater numbers of alterations and poorer overall survival for multiple component genes. While the intricacies of CRL2pVHL complex gene regulation require additional research, it is evident that multiple causes for the deregulation of these genes must be considered in HCC, including non-traditional mechanisms.
Insights
Dysregulation of ubiquitin-proteasome pathway genes, including CRL2pVHL components, is linked to hepatocellular carcinoma (HCC) progression. Multiple alterations correlate with poorer survival, suggesting novel therapeutic targets.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Ubiquitin-proteasome pathway gene dysregulation (copy number alteration, hypomethylation, miRNA deregulation) contributes to cancer.
- Hepatocellular carcinoma (HCC) presents challenges for identifying druggable targets.
- The CRL2pVHL E3 ubiquitin ligase complex is a key component of this pathway.
Purpose of the Study:
- To investigate alterations in CRL2pVHL component genes in HCC.
- To explore the role of miRNA deregulation in CRL2pVHL overexpression.
- To assess the correlation between gene alterations and patient survival.
Main Methods:
- Analysis of 377 HCC and 59 non-malignant liver tissues.
- Examination of mRNA expression, DNA methylation, and copy number alterations.
- Identification and correlation analysis of downregulated miRNAs targeting CRL2pVHL components.
- Multidimensional survival analysis integrating various molecular data.
Main Results:
- Upregulation of CRL2pVHL component genes was common in HCC, linked to hypomethylation and copy number increase.
- Overexpression not explained by DNA alterations suggests other regulatory mechanisms.
- 66 miRNAs, including 39 novel ones, were downregulated and predicted to target CRL2pVHL components.
- Downregulated miRNAs (e.g., hsa-miR-101-3p, hsa-miR-139-5p) correlated with component gene overexpression.
- Increased numbers of molecular alterations in CRL2pVHL genes significantly associated with poorer overall survival.
Conclusions:
- Multiple mechanisms, including non-traditional ones like miRNA deregulation, contribute to CRL2pVHL gene dysregulation in HCC.
- miRNA downregulation is a potential driver of CRL2pVHL overexpression in HCC.
- Combined molecular alterations in CRL2pVHL genes serve as a prognostic indicator for HCC survival.
- Further research into CRL2pVHL complex regulation may reveal novel therapeutic strategies for HCC.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Abnormal Proliferation
Cell Specific Gene Expression
Mechanisms of Retrovirus-induced Cancers
Negative Regulator Molecules
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....

